论文部分内容阅读
子宫内膜癌在我国较西方国家少见,约占妇科癌肿的6.3～11.0%,但近年来有增长趋势。大约75%的子宫内膜癌患者虽属临床Ⅰ期,但预后仍有所不同。兹就影响子宫内膜癌预后的因素简述如下。一、临床分期临床分期与预后密切相关。大多数研究表明Ⅱ期癌的淋巴结转移率和死亡率均比Ⅰ期高。Ⅲ期和Ⅳ期的预后更差。分段诊刮分辨子宫颈管是否受累有助于临床分期和制定治疗方案。FIGO 分期法根据宫腔深度(以8cm 为界)将Ⅰ期分为Ⅰa 和Ⅰb 二个亚期。多数学者认为宫腔较大的Ⅰ期患者生存率差,但亦有认为子宫大小不是子宫内膜癌的预
Endometrial cancer is rare in our country than in western countries, accounting for 6.3 ~ 11.0% of gynecological cancer, but in recent years there is a growing trend. About 75% of patients with endometrial cancer is a clinical stage Ⅰ, but the prognosis is still different. Here are some of the factors that affect the prognosis of endometrial cancer. First, the clinical stage of the clinical stage and prognosis are closely related. Most studies have shown that stage Ⅱ cancer lymph node metastasis and mortality were higher than the phase Ⅰ. Stage III and IV prognosis worse. Segmented curettage identification of cervical canal involvement is helpful to clinical staging and development of treatment options. FIGO staging method according to uterine cavity depth (8cm for the community) will be divided into Ⅰ Ⅰ Ⅰb and Ⅰ b two sub-phase. Most scholars believe that the larger uterine stage Ⅰ survival rate is poor, but there are also that the size of the uterus is not the endometrial cancer pre-